| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 80.269 | 64.132 | 53.921 | 60.043 | 77.016 | 74.125 | 72.679 | 88.999 | 102.665 | 133.762 |
| Total Income - EUR | 80.565 | 66.461 | 53.921 | 60.087 | 77.279 | 76.186 | 80.883 | 89.406 | 102.666 | 133.870 |
| Total Expenses - EUR | 80.482 | 65.011 | 57.560 | 73.409 | 76.246 | 75.284 | 78.716 | 88.230 | 100.838 | 128.913 |
| Gross Profit/Loss - EUR | 83 | 1.450 | -3.639 | -13.323 | 1.034 | 902 | 2.167 | 1.176 | 1.827 | 4.957 |
| Net Profit/Loss - EUR | 52 | 121 | -4.764 | -13.924 | 261 | 140 | 1.510 | 281 | 800 | 1.583 |
| Employees | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anafarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.403 | 6.728 | 6.614 | 6.493 | 6.892 | 6.761 | 6.611 | 6.631 | 6.611 | 6.575 |
| Current Assets | 58.236 | 49.276 | 36.748 | 26.957 | 24.980 | 33.701 | 25.534 | 28.006 | 38.064 | 35.794 |
| Inventories | 52.273 | 35.069 | 25.140 | 16.375 | 16.335 | 11.898 | 17.766 | 17.658 | 21.355 | 22.770 |
| Receivables | 5.160 | 13.102 | 10.986 | 6.068 | 5.318 | 6.219 | 3.772 | 6.496 | 11.141 | 3.903 |
| Cash | 802 | 1.106 | 621 | 4.514 | 3.327 | 15.584 | 3.996 | 3.852 | 5.568 | 9.121 |
| Shareholders Funds | 8.457 | 8.982 | 4.066 | -11.696 | -13.137 | -12.747 | -11.032 | -10.785 | -9.952 | -8.314 |
| Social Capital | 4.499 | 4.454 | 4.378 | 4.298 | 4.215 | 4.135 | 4.043 | 4.056 | 4.043 | 4.021 |
| Debts | 55.194 | 48.024 | 40.282 | 46.522 | 50.091 | 58.196 | 43.177 | 45.422 | 54.627 | 46.802 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.879 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Anafarm S.r.l.